Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.26p
   
  • Change Today:
      0.001p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 1,121,997
  • Market Cap: £5.50m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
18.43% above the market average18.43% above the market average18.43% above the market average18.43% above the market average18.43% above the market average
58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
60.71% above the market average60.71% above the market average60.71% above the market average60.71% above the market average60.71% above the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Price Chg 3m
50.99% above the market average50.99% above the market average50.99% above the market average50.99% above the market average50.99% above the market average
65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average65.22% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.45% above the market average39.45% above the market average39.45% above the market average39.45% above the market average39.45% above the market average
76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average76.19% above the sector average
Momentum 20
0.44% above the market average0.44% above the market average0.44% above the market average0.44% above the market average0.44% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average43.62% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
57.43% below the market average57.43% below the market average57.43% below the market average57.43% below the market average57.43% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
49.46% below the market average49.46% below the market average49.46% below the market average49.46% below the market average49.46% below the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average
Cash
40.86% below the market average40.86% below the market average40.86% below the market average40.86% below the market average40.86% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.26p
Change Today 0.001p
% Change 0.39 %
52 Week High 1.22
52 Week Low 0.20
Volume 1,121,997
Shares Issued 2,148.96m
Market Cap £5.50m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.14% below the market average3.14% below the market average3.14% below the market average3.14% below the market average3.14% below the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average
Price Trend
96.07% below the market average96.07% below the market average96.07% below the market average96.07% below the market average96.07% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 20-Jun-2025

Time Volume / Share Price
15:09 328,000 @ 0.25p
08:48 450,000 @ 0.24p
08:17 340,426 @ 0.24p
08:10 3,571 @ 0.28p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page